sulfur hexafluoride has been researched along with Age-Related Macular Degeneration in 33 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (12.12) | 18.2507 |
2000's | 19 (57.58) | 29.6817 |
2010's | 8 (24.24) | 24.3611 |
2020's | 2 (6.06) | 2.80 |
Authors | Studies |
---|---|
Bayoumy, ASM; Elmohamady, MN; Faramawi, HM; Khalil, MTI; Rateb, M | 1 |
Agarwal, A; Aggarwal, K; Gupta, V; Handa, S; Markan, A | 1 |
Byeon, SH; Choi, HJ; Choi, M; Chung, B; Lee, J; Shin, JY | 1 |
Karska-Basta, I; Kubicka-Trząska, A; Miniewicz, J; Romanowska-Dixon, B | 1 |
Abboud, M; Benzerroug, M; Milazzo, S | 1 |
Hattenbach, LO; Höhn, F; Mirshahi, A | 1 |
Auriol, S; Lequeux, L; Mahieu, L; Pagot-Mathis, V; Quintyn, JC | 1 |
Gotoh, N; Hasegawa, T; Ooto, S; Otani, A; Sasahara, M; Tamura, H; Tsujikawa, A; Yamashiro, K; Yoshimura, N | 1 |
Beckford-Torngren, C; Benítez-Herreros, J; Cámara-González, C; Castro-Rebollo, M; Gros-Otero, J | 1 |
Hirano, Y; Ito, Y; Mizutani, T; Ogura, Y; Takase, A; Yasukawa, T; Yoshida, M | 1 |
Brieden, M; Gümbel, H; Hattenbach, LO; Koch, F | 1 |
Hesse, L; Schulze, SD | 1 |
Marek, J; Nizankowska, MH; Oficjalska-Młyńczak, J; Zajac-Pytrus, H | 1 |
Bornfeld, N; Foerster, MH; Gabel-Pfisterer, A; Heimann, H; Jandeck, C; Kellner, U; Laue, J | 1 |
Kittantong, A; Ratanasukon, M | 1 |
Heinzl, H; Mozaffarieh, M; Sacu, S; Wedrich, A | 1 |
Axer-Siegel, R; Ehrlich, R; Ron, Y; Rosenblatt, I; Weinberger, D | 1 |
Chen, MS; Fang, IM; Lin, YC; Yang, CH; Yang, CM | 1 |
Eter, N; Helb, HM; Holz, FG; Meyer, CH; Scholl, HP | 1 |
Jacobi, KW; Pavlovic, S; Scharwey, K | 1 |
Blodi, BA; Elner, SG; Hassan, AS; Johnson, MW; Poliner, LS; Regillo, CD; Schneiderman, TE; Tornambe, PE | 1 |
Jochmann, C; Meier, P; Wiedemann, P; Zeumer, C | 1 |
Daneshvar, H; Kertes, PJ; Leonard, BC; Peyman, GA | 1 |
Framme, C; Gabel, VP; Lohmann, CP; Roider, J; Sachs, HG; Spiegel, D; Toukhy, HE | 1 |
Krepler, K; Kruger, A; Stur, M; Tittl, M; Wedrich, A | 1 |
Heller, G; Hesse, L; Kroll, P; Schroeder, B | 1 |
Averbukh, E; Berger, AR; Devenyi, RG; Lam, WC | 1 |
Hesse, L; Kroll, P | 1 |
Hay, SR; Madonna, RJ | 1 |
Cox, TA; Fekrat, S; Haupert, CL; Jaffe, GJ; McCuen, BW; Postel, EA; Steuer, ER; Toth, CA | 1 |
Gümbel, HO; Hattenbach, LO; Klais, C; Koch, FH | 1 |
Abe, T; Kano, T; Tamai, M; Yoshida, M | 1 |
Lewis, H | 1 |
3 trial(s) available for sulfur hexafluoride and Age-Related Macular Degeneration
Article | Year |
---|---|
[Combined intravitreal injection of bevacizumab and SF6 gas for treatment of submacular hemorrhage secondary to age-related macular degeneration].
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Drug Therapy, Combination; Female; Humans; Injections; Macula Lutea; Macular Degeneration; Male; Retinal Hemorrhage; Sulfur Hexafluoride; Treatment Outcome; Vitreous Body | 2010 |
Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aneurysm; Eye Injuries; Female; Fibrinolytic Agents; Fluorocarbons; Humans; Injections; Macula Lutea; Macular Degeneration; Male; Middle Aged; Postoperative Complications; Prone Position; Retinal Hemorrhage; Retinal Vessels; Retrospective Studies; Sulfur Hexafluoride; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome; Visual Acuity; Vitreous Body | 1999 |
Intravitreal injection of tissue plasminogen activator and gas in subretinal hemorrhage caused by age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Female; Fibrinolytic Agents; Fluorescein Angiography; Humans; Injections; Macular Degeneration; Male; Pilot Projects; Recombinant Proteins; Retinal Hemorrhage; Sulfur Hexafluoride; Thrombolytic Therapy; Tissue Plasminogen Activator; Visual Acuity; Vitreous Body | 2000 |
30 other study(ies) available for sulfur hexafluoride and Age-Related Macular Degeneration
Article | Year |
---|---|
Sulphur hexafluoride (SF6) intravitreal injection combined with argon laser photocoagulation for treatment of optic disc pit maculopathy.
Topics: Argon; Follow-Up Studies; Humans; Intravitreal Injections; Lasers; Macular Degeneration; Optic Disk; Retrospective Studies; Sulfur Hexafluoride; Tomography, Optical Coherence; Vitrectomy | 2021 |
Subretinal Hemorrhage Complicating Retinal Angiomatous Proliferation in Tubercular Retinal Vasculitis.
Topics: Adult; Cell Proliferation; Fibrinolytic Agents; Fluorescein Angiography; Humans; Macular Degeneration; Male; Retinal Hemorrhage; Retinal Vasculitis; Retrospective Studies; Sulfur Hexafluoride; Tissue Plasminogen Activator; Vitrectomy | 2022 |
Anti-Vascular Endothelial Growth Factor with Gas for Submacular Hemorrhage.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Bevacizumab; Combined Modality Therapy; Endotamponade; Female; Fluorescein Angiography; Fluorocarbons; Humans; Intravitreal Injections; Macular Degeneration; Male; Middle Aged; Ranibizumab; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity | 2016 |
[Managment of subretinal heamorrhages within the macular area using intravitreal injections of recombined tissue plasminogen activator, sulphur hexafluoride and ranihizumab--preliminary report].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Drug Therapy, Combination; Humans; Intravitreal Injections; Macula Lutea; Macular Degeneration; Middle Aged; Ranibizumab; Retinal Hemorrhage; Sulfur Hexafluoride; Tissue Plasminogen Activator; Tomography, Optical Coherence; Visual Acuity; Young Adult | 2015 |
[Treatment of macular hematoma complicating AMD by vitrectomy, subretinal r-TPA injection, intravitreal injection of bevacizumab combined with gas tamponade: Report of 4 cases].
Topics: Aged; Aged, 80 and over; Bevacizumab; Female; Hematoma; Humans; Intravitreal Injections; Macular Degeneration; Male; Recombinant Proteins; Retinal Hemorrhage; Sulfur Hexafluoride; Tissue Plasminogen Activator; Vitrectomy | 2017 |
[Pars plana vitrectomy, subretinal injection of recombinant tissue plasminogen activator and fluid-gas exchange in the management of massive submacular hemorrhages secondary to age-related macular degeneration].
Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Combined Modality Therapy; Female; Fibrinolytic Agents; Fluorescein Angiography; France; Hematoma; Humans; Injections, Intraocular; Macular Degeneration; Male; Photochemotherapy; Prognosis; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Tissue Plasminogen Activator; Treatment Outcome; Visual Acuity; Vitrectomy | 2010 |
Prognostic factors of vitreous hemorrhage secondary to exudative age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Exudates and Transudates; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Lens Implantation, Intraocular; Macular Degeneration; Male; Middle Aged; Phacoemulsification; Photochemotherapy; Prognosis; Retrospective Studies; Sulfur Hexafluoride; Tomography, Optical Coherence; Visual Acuity; Vitrectomy; Vitreous Hemorrhage | 2010 |
[Management of subretinal hemorrhage with r-TPA, SF-6 and ranibizumab].
Topics: Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Choroidal Neovascularization; Combined Modality Therapy; Drug Therapy, Combination; Emergencies; Humans; Injections, Intraocular; Macular Degeneration; Male; Paracentesis; Ranibizumab; Recombinant Proteins; Recurrence; Retinal Hemorrhage; Sulfur Hexafluoride; Tissue Plasminogen Activator; Vitreous Body | 2010 |
Pneumatic displacement of submacular hemorrhage with or without tissue plasminogen activator.
Topics: Aged; Aged, 80 and over; Aneurysm, Ruptured; Angiogenesis Inhibitors; Combined Modality Therapy; Fibrinolytic Agents; Follow-Up Studies; Humans; Intravitreal Injections; Macula Lutea; Macular Degeneration; Middle Aged; Photochemotherapy; Prone Position; Recurrence; Retinal Artery; Retinal Diseases; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Tissue Plasminogen Activator; Treatment Outcome; Visual Acuity | 2011 |
[Intravitreal injection of rt-PA and gas in the management of minor submacular haemorrhages secondary to age-related macular degeneration].
Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Female; Fluorescein Angiography; Humans; Injections; Macular Degeneration; Male; Middle Aged; Ophthalmoscopy; Recombinant Proteins; Retinal Hemorrhage; Sulfur Hexafluoride; Tissue Plasminogen Activator; Visual Acuity; Vitreous Body | 2002 |
Tissue plasminogen activator plus gas injection in patients with subretinal hemorrhage caused by age-related macular degeneration: predictive variables for visual outcome.
Topics: Aged; Aged, 80 and over; Combined Modality Therapy; Female; Fluorocarbons; Humans; Injections; Macular Degeneration; Male; Middle Aged; Prone Position; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Tissue Plasminogen Activator; Visual Acuity; Vitrectomy; Vitreous Body | 2002 |
[Treatment of subretinal macular hemorrhages with intravitreous injections of tissue plasminogen activator and SF6 gas].
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Injections; Macular Degeneration; Male; Middle Aged; Retinal Diseases; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Tissue Plasminogen Activator; Treatment Outcome; Visual Acuity | 2003 |
Long-term results after surgical extraction of subfoveal choroidal neovascular membranes with and without haemorrhage in age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Female; Fluorescein Angiography; Follow-Up Studies; Fovea Centralis; Humans; Macular Degeneration; Male; Membranes; Middle Aged; Prognosis; Recurrence; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Visual Acuity; Vitrectomy | 2004 |
Results of intravitreal tissue plasminogen activator and expansile gas injection for submacular haemorrhage in Thais.
Topics: Adult; Aged; Aged, 80 and over; Choroidal Neovascularization; Combined Modality Therapy; Fluorocarbons; Follow-Up Studies; Gases; Humans; Macular Degeneration; Middle Aged; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Thailand; Tissue Plasminogen Activator; Treatment Outcome; Visual Acuity | 2005 |
In-patient management and treatment satisfaction after intravitreous plasminogen activator injection.
Topics: Drug Therapy, Combination; Fibrinolytic Agents; Follow-Up Studies; Humans; Injections; Inpatients; Macular Degeneration; Patient Satisfaction; Prone Position; Prospective Studies; Recombinant Proteins; Retinal Hemorrhage; Sulfur Hexafluoride; Surveys and Questionnaires; Tissue Plasminogen Activator; Visual Acuity; Vitreous Body | 2006 |
Pneumatic displacement of submacular hemorrhage due to age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Female; Fluorocarbons; Humans; Injections; Macular Degeneration; Male; Pressure; Prone Position; Retinal Hemorrhage; Sulfur Hexafluoride; Time Factors; Visual Acuity | 2007 |
Effects of intravitreal gas with or without tissue plasminogen activator on submacular haemorrhage in age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Female; Fibrinolytic Agents; Fluorocarbons; Gases; Humans; Macular Degeneration; Male; Middle Aged; Prognosis; Recombinant Proteins; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Tissue Plasminogen Activator; Treatment Outcome; Visual Acuity; Vitreous Body | 2009 |
Combined treatment of acute subretinal haemorrhages with intravitreal recombined tissue plasminogen activator, expansile gas and bevacizumab: a retrospective pilot study.
Topics: Acute Disease; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Combined Modality Therapy; Female; Fibrinolytic Agents; Humans; Injections; Macular Degeneration; Male; Middle Aged; Pilot Projects; Prone Position; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Tissue Plasminogen Activator; Treatment Outcome; Visual Acuity; Vitreous Body | 2008 |
[Early posterior capsule fibrosis after combined cataract and vitreoretinal surgery with intraocular air/SF6 gas tamponade].
Topics: Aged; Air; Cataract; Eye Diseases; Female; Fibrosis; Follow-Up Studies; Humans; Lens Capsule, Crystalline; Lenses, Intraocular; Macular Degeneration; Male; Phacoemulsification; Postoperative Complications; Reoperation; Retinal Diseases; Retrospective Studies; Sulfur Hexafluoride; Vitrectomy; Vitreous Body | 1998 |
[Management of submacular hemorrhage by tissue plasminogen activator and SF(6) gas injection].
Topics: Aged; Electroretinography; Female; Fibrinolytic Agents; Fluorescein Angiography; Fundus Oculi; Humans; Injections; Laser Coagulation; Macular Degeneration; Male; Retinal Hemorrhage; Sulfur Hexafluoride; Time Factors; Tissue Plasminogen Activator; Visual Acuity; Vitreous Body | 1999 |
Management of submacular hemorrhage with intravitreal sulfur hexafluoride: a pilot study.
Topics: Fluorescein Angiography; Fundus Oculi; Humans; Indocyanine Green; Injections; Macula Lutea; Macular Degeneration; Pilot Projects; Prone Position; Retinal Hemorrhage; Sulfur Hexafluoride; Treatment Outcome; Visual Acuity; Vitreous Body | 1999 |
[Clinical results of intravitreal administration of tissue-type plasminogen activator (tPA) and gas for removal of subretinal hemorrhage in senile macular degeneration].
Topics: Aged; Choroidal Neovascularization; Combined Modality Therapy; Female; Humans; Laser Coagulation; Macular Degeneration; Male; Middle Aged; Retinal Hemorrhage; Sulfur Hexafluoride; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome; Vitreous Body | 2000 |
Quantitative effect of intravitreally injected tissue plasminogen activator and gas on subretinal hemorrhage.
Topics: Acute Disease; Aged; Aged, 80 and over; Female; Fibrinolytic Agents; Fluorocarbons; Humans; Injections; Macular Degeneration; Male; Middle Aged; Retina; Retinal Hemorrhage; Sulfur Hexafluoride; Tissue Plasminogen Activator; Treatment Outcome; Visual Acuity; Vitreous Body | 2000 |
Pneumatic displacement of submacular hemorrhage.
Topics: Humans; Macula Lutea; Macular Degeneration; Plasminogen Activators; Retinal Hemorrhage; Retinal Vessels; Sulfur Hexafluoride; Thrombolytic Therapy; Tissue Plasminogen Activator; Visual Acuity | 2000 |
Pneumatic displacement of submacular hemorrhage.
Topics: Fibrinolytic Agents; Humans; Injections; Macula Lutea; Macular Degeneration; Retinal Hemorrhage; Retinal Vessels; Sulfur Hexafluoride; Thrombolytic Therapy; Tissue Plasminogen Activator; Visual Acuity | 2000 |
Intravitreal injection of tissue plasminogen activator and gas bubble for treatment of subretinal hemorrhage in ARMD.
Topics: Aged; Humans; Injections; Macular Degeneration; Male; Plasminogen Activators; Retina; Retinal Hemorrhage; Sulfur Hexafluoride; Tissue Plasminogen Activator; Visual Acuity; Vitreous Body | 2000 |
Pars plana vitrectomy, subretinal injection of tissue plasminogen activator, and fluid-gas exchange for displacement of thick submacular hemorrhage in age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Female; Fibrinolytic Agents; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Humans; Injections; Macular Degeneration; Male; Recurrence; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Tissue Plasminogen Activator; Treatment Outcome; Visual Acuity; Vitrectomy | 2001 |
Intravitreous injection of tissue plasminogen activator and gas in the treatment of submacular hemorrhage under various conditions.
Topics: Aged; Aged, 80 and over; Drug Therapy, Combination; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Injections; Macula Lutea; Macular Degeneration; Male; Middle Aged; Plasminogen Activators; Prone Position; Prospective Studies; Recombinant Proteins; Retinal Hemorrhage; Safety; Sulfur Hexafluoride; Tissue Plasminogen Activator; Visual Acuity; Vitreous Body | 2001 |
Visual function after removal of subretinal neovascular membranes in patients with age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Female; Fibrosis; Fluorescein Angiography; Humans; Indocyanine Green; Macular Degeneration; Male; Middle Aged; Pigment Epithelium of Eye; Postoperative Care; Silicone Oils; Sulfur Hexafluoride; Visual Acuity; Visual Field Tests; Visual Fields; Vitrectomy | 2001 |
tPA and gas in submacular hemorrhage.
Topics: Fibrinolytic Agents; Humans; Injections; Macular Degeneration; Prognosis; Retinal Hemorrhage; Sulfur Hexafluoride; Tissue Plasminogen Activator; Visual Acuity | 2002 |